Pediatric Cardiology

Latest News

Thyroid Dysfunction Common in Children Treated With Amiodarone

Children and young adults treated with amiodarone have a significant likelihood for thyroid dysfunction soon after treatment initiation.

Oil, Gas Well Exposure May Increase Risk for Congenital Heart Defects

Pregnant women living near more oil and natural gas development activity have a greater chance of giving birth to children with congenital heart defects.

Outcomes of Cardiac Evaluations in Pediatric Status Asthmaticus

While pediatric patients with asthma may experience cardiac symptoms, they are rarely a sign of underlying cardiac disease.

Long-Term Ischemic Stroke Risk Increased in Children After Cardiac Procedures

Pediatric cardiac disease is associated with an increased risk for arterial ischemic stroke following cardiac procedures.

Risk for Cancer Higher in Those With Congenital Heart Disease

Children and young adult patients with congenital heart disease have an increased risk for developing cancer.

FDA Approves Amlodipine Oral Suspension for Pediatric Hypertension

The FDA has approved Katerzia, a ready-to-use, oral suspension formulation of amlodipine.

Rivaroxaban Appears Safe, Effective for Pediatric Acute Venous Thromboembolism

Results of the study showed that the rate of symptomatic recurrent VTE – the primary end point – was similar in both treatment groups with 1.2% of patients experiencing a recurrent event in the rivaroxaban group compared with 3.0% in the standard anticoagulation group.

Guidance Issued for Management of Fontan Circulation

A scientific statement with recommendations for follow-up care in patients with Fontan circulation surviving into adulthood was published.

Higher BMI in Male Teens Tied to Cardiomyopathy in Adulthood

Increased BMI in adolescence is associated with an increased risk for cardiomyopathy in adulthood among men.

First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients

The FDA has approved Fragmin a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism.